Morgan Stanley
TGX

Morgan Stanley’s THERAGENICS CORP TGX Stock Holding History

Morgan Stanley’s Portfolio TGX Stock Details TGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-17,400
Closed -$38K – 6446
2013
Q3 		$38K Sell
17,400
-22,983
-57% -$49K ﹤0.01% 5230
2013
Q2 		$84K Buy
+40,383
New +$72.3K ﹤0.01% 5115

Morgan Stanley's TGX Position: Q4 2013 in Review

Morgan Stanley sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 17,400 shares — an estimated $38K sold.

Morgan Stanley first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $84K in Q2 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.

  • Morgan Stanley reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
  • Morgan Stanley sold 17,400 THERAGENICS CORP shares in Q4 2013, an estimated $38K.
  • Morgan Stanley first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
  • Morgan Stanley's THERAGENICS CORP position peaked at $84K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.

Based on Morgan Stanley's 13F filing for Q4 2013, filed 13 Feb 2014.